Citation

Bowden CL, Krishnan AA. Expert Opin. Pharmacother. 2004; 5(5): 1101-1107.

Copyright

(Copyright © 2004, Informa - Taylor and Francis Group)

DOI

10.1517/14656566.5.5.1101

PMID

15155111

Abstract

Bipolar disorder (BPD) is a common, severe and recurrent mood disorder associated with high rates of comorbidities, suicide, dysfunction and a high socioeconomic burden. Although the management of BPD has traditionally focused on the acute treatment of mania, the chronic nature of BPD necessitates long-term maintenance treatment. Bipolar depression is the predominant abnormal affective pole and causes greater disability and economic burden than mania. Maintenance pharmacotherapy can reduce rates of future episodes, and subsequently, the associated risks, functional disability and economic burden of bipolar illness.

Language: en

Keywords

Bipolar Disorder; Comorbidity; Cost-Benefit Analysis; Humans